Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
about
The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells.Cobalt(III) Chaperone Complexes of Curcumin: Photoreduction, Cellular Accumulation and Light-Selective Toxicity towards Tumour Cells.Influence of self-assembly on intercalative DNA binding interaction of double-chain surfactant Co(III) complexes containing imidazo[4,5-f][1,10]phenanthroline and dipyrido[3,2-d:2'-3'-f]quinoxaline ligands: experimental and theoretical study.Synthesis, magnetic properties and dynamic behavior of cobalt complexes with an anthracene-containing dioxolene ligand.The influence of the ancillary ligand on the potential of cobalt(iii) complexes to act as chaperones for hydroxamic acid-based drugs.Reversible magnetogenic cobalt complexes
P2860
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
@en
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
@nl
type
label
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
@en
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
@nl
prefLabel
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
@en
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
@nl
P2093
P2860
P356
P1433
P1476
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
@en
P2093
Byung J Kim
Jack K Clegg
Paul D Bonnitcha
Peter Turner
Rosalie K Hocking
Suzanne M Neville
Trevor W Hambley
P2860
P304
11293-11304
P356
10.1039/C2DT30727H
P407
P577
2012-08-10T00:00:00Z